De-Risking the ADC Pipeline: An Integrated Platform Approach to Engineering Promising Therapies
- Navigating the complexities of ADC development from challenges in target selection and patient stratification to understanding resistance mechanisms
- Discovering how Tempus’ integrated platform uses multimodal real-world data, AI, and patient-derived organoids to help inform development strategies and support patient population identification
- Exploring how an established diagnostic engine and a connected oncologist network can help facilitate ADC adoption and support a streamlined path to commercialization